Cellosaurus cell line FA34 (CVCL

Cross-references
Cell line name	FA34
Accession	CVCL_IU78
Resource Identification Initiative	To cite this cell line use: FA34 (RRID:CVCL_IU78)
Comments	Doubling time: ~34 hours (PubMed=25653542). Donor information: Established from a patient treated prior to cell line establishment with paclitaxel, pemetrexed, cisplatinum and erlotinib (PubMed=25653542). Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
Sequence variations	Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E6A20 v2 fusion (PubMed=25653542).
Disease	Lung adenocarcinoma (NCIt: C3512)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell	Female
Age at sampling	34Y
Category	Cancer cell line
Publications	PubMed=25653542; DOI=10.2147/OTT.S71242; PMCID=PMC4303463 David Chi-Leung Lam, Susan Y. Luo, Wen Deng, Johnny Sheung-Him Kwan, Jaime Rodriguez-Canales, Annie Lai-Man Cheung, Grace H.-W. Cheng, Chi-Ho Lin, Ignacio Ivan Wistuba, Pak Chung Sham, Thomas Shek-Kong Wan, George Sai-Wah Tsao; Oncogenic mutation profiling in new lung cancer and mesothelioma cell lines. Onco Targets Ther. 8:195-209(2015)
Encyclopedic resources	Wikidata; Q54833206
Polymorphism and mutation databases	Cosmic; 2559131
Entry history
Entry creation	03-Mar-2017
Last entry update	27-Nov-2025
Version number	6